Skip to main content
Download PDF

Sexual function and sexual quality of life in men with genital warts: a cross-sectional study

Reproductive Health volume 19, Article number: 102 (2022) Cite this article

Abstract

Background

Human papillomavirus is the most common sexually transmitted infection, usually passing from one person to another after the first sexual activity. Infection with this virus and the occurrence of genital warts (GWs) could have several effects on patients’ health. This study was performed to evaluate the sexual function and sexual quality of life (SQOL) in men with GWs.

Methods

This cross-sectional study was conducted from September 2019 to March 2020 with a sample size of 105 men with GWs in the dermatology clinic of Shahid Faghihi Hospital in Shiraz University of Medical Sciences, Iran. Data were collected using a demographic questionnaire, the International Index of Erectile Function (IIEF), and the Sexual Quality of Life-Men (SQOL-M) questionnaires and analyzed by descriptive and inferential tests with SPSS software version 22.

Results

The mean score for overall sexual function in men was 48.50 ± 8.89. About 35.2% of men had overall sexual dysfunction (SD). The highest disorder rate was related to the erection domain (85.7%), and the lowest was related to the desire domain (5.7%). In the erection domain, most men (54.3%) experienced mild to moderate erectile dysfunction. The mean score for SQOL-M was 38.36 ± 14.47, and 56.2% of them had a good SQOL.

Conclusions

GWs affected men’s erection more than the other sexual function domains. SD in men with GWs has a significant impact on their SQOL and ED was associated with impaired SQOL. Therefore, it is recommended to pay more attention to SD screening alongside SQOL assessment of men with GW.

Plain language summary

Human papillomavirus is the most common sexually transmitted infection. Infection with this virus and the occurrence of genital warts (GWs) could have several effects on men and women’s health. In this cross-sectional study, we examined the sexual function and sexual quality of life (SQOL) in men with GWs. Of the 105 men, 35.2% had sexual dysfunction (SD). The highest disorder rate was related to the erection domain (85.7%), and the lowest was related to the desire domain (5.7%). In the erection domain, most men (54.3%) experienced mild to moderate erectile dysfunction. 56.2% of them had a good SQOL. SD in men with GWs has a significant impact on their SQOL. Therefore, it is recommended that assessment of sexual function and SQOL should be done when men with GWs refer to health services.

Peer Review reports

Background

Genital human papillomavirus (HPV) infection is the most common sexually transmitted infections (STIs), usually passing from one person to another after the first sexual activity [1]. According to the World Health Organization, in 2019, about 600 million men and women worldwide were infected by the virus [2]. Although most studies have focused on women and the association of HPV infection with cervical cancer, the prevalence of the virus in men is also significant. The results of the National Health and Nutrition Examination Surveys between 2013 and 2014 in the United States showed that 42.2% of American men aged from 14 to 59 years have some form of genital HPV infections, and 2.23% of men in this age group reported a history of genital warts (GWs) [3, 4]. HPV and related diseases are not specific to women, and Genital HPV can develop as GWs in both women and men. In Commercially Insured US Populations, the incidence of GWs was 1.2 cases per PY 1000 among women and 1.1 cases per PY 1000 among men, with the highest incidence among women aged from 20 to 24 years and men 25 to 29 years [5].

Several studies have reported GWs morbidity as a psychosocial burden, including worries, emotional and sexual effects, self-image concern, and control/life impact. However, women experienced more Burden than men. Men were also affected by the psychological effects of GWs [6, 7].

In the literature, it has been shown that STIs have negative effects on men’s mental health and sexual function [8,9,10]. Some studies also indicate sexual-related concern in men with GWs [6, 7]. Because the sexual response cycle reflects biopsychosocial interaction, these concerns appear to affect sexual function, but there is limited evidence [11].

One of the most critical issues in sexual health is the quality of sexual life. Previous studies have shown that GWs in men are associated with severe damage to their health-related quality of life [7, 12, 13]. Based on the available shreds of evidence, no studies have focused on Sexual Quality of Life-Men (SQOL-M) with GWs. Therefore, this study was designed to evaluate the sexual function and SQOL in men with GWs.

Methodology

Study design

This cross-sectional study was conducted from September 2019 to March 2020 in the dermatology clinic of Shahid Faghihi Hospital at Shiraz University of Medical Sciences, Iran, among men with GWs.

Study population

The study included men whose GWs were diagnosed by a dermatologist based on clinical signs in their skin. The sample size was determined by considering a confidence interval of 95%, the study power of 90% and according to data of previous study with an effect size of 0.35 [11]. The minimum sample size of 87 was obtained; also, considering 20% of the sample loss, 105 samples were considered. Inclusion criteria included: 18 years and above (cut off age for adult men), having sex in the last 4 weeks, absence of history or current of mental illness under treatment, no use of drugs affecting sexual function (antihypertensive drugs, cardiovascular drugs, antidepressants, opiates, blood sugar regulators and amphetamines), and no chronic diseases such as diabetes, hypertension, autoimmune diseases, and heart disease. The exclusion criterion was withdrawal from the company after enrollment.

Data collection

Sociodemographic information and data about sexual orientation and sexual style were collected by a researcher-made questionnaire. Sexual function was assessed by the International Index of Erectile Function (IIEF), a self-report questionnaire. The questionnaire consists of 15 items, each of which is graded on a 5- or 6-point Likert-type response scale and examines five domains: erection, orgasm, desire, intercourse satisfaction, and overall satisfaction. A higher score indicates better sexual function, and the maximum acceptable score of 75 indicates the best sexual status in various areas [14, 15]. The status of patients’ erectile function was also considered as follows: 0–10 (severe erectile dysfunction (ED)), 11–16 (moderate ED), 17–21 (moderate to mild ED), 22–25 (mild ED), 26–30 (no ED) [16].

The SQOL-M was assessed using the 11-item questionnaire. The total score is between 11 and 66, and a higher score indicates a better SQOL-M [17]. A score of 11–22 was considered a poor class, a score of 23–33 was considered a middle class, and a score of 34 and above was considered a good class [18].

Ethical issues

The research project was approved by the ethics committee of Shiraz University of Medical Sciences (IR.SUMS.REC.1398.743). Written informed consent was obtained from all the participants.

Data analysis

The data were summarized using frequencies and percentages. Continuous variables were summarized as the mean and standard deviation. Categorical variables were compared using the χ2 test or Fisher’s exact test. Correlations between variables were determined using Spearman and Pearson correlation coefficient. logistic regression analysis was used to evaluate the association between ED and SQOL-M. The data were analyzed by SPSS software version 22 (SPSS Inc., Chicago, IL, USA). P value < 0.05 was considered significant.

Results

A total of 105 men completed the study. The mean age of men was 30.86 ± 7.3 years, and the mean duration of GWs was 19.92 ± 20.45 months. Table 1 shows some demographic characteristics and their sexual relationships (Table 1).

Table 1 Baseline characteristics of participants
Full size table

According to Tables 2 and 3, the mean score for overall sexual function in men was 48.50 ± 8.89, and according to the subscales of the IIEF Questionnaire, 35.2% of men had general dysfunction. Among the different domains of this disorder, the highest rate of disorder was related to the erectile domain (85.7%), and the lowest rate was related to the desire domain (5.7%).

Table 2 Mean score of sexual function and subscales measured by the International Index of Erectile Function (IIEF) score in men with genital warts
Full size table
Table 3 Frequency of sexual dysfunction measured by the International Index of Erectile Function (IIEF) score in men with genital warts
Full size table

Table 4 shows that in the area of erection, most men (54.3%) experienced mild to moderate ED. The total score of IIEF and domains did not correlate with age, time since onset of genital warts, and education. The mean total score of SQOL-M in this study was 38.36 ± 14.47, and Table 4 showed that 56.2% of individuals had a score of 34 and above and were classified as the good SQOL.

Table 4 Severity of erectile dysfunction (ED) and Sexual quality of life status measured by the Sexual Quality of Life-Men (SQOL-M) in men with genital warts
Full size table

The SQOL-M scores correlated significantly with education and all IIEF domains but not with age and time since the onset of GWs (Table 5).

Table 5 Correlations of sexual quality of life (SQOL-M score) with age, time since onset of genital warts, and the International Index of Erectile Function (IIEF) domains
Full size table

Logestic regression analysis revealed that ED in men was associated with 61% increase in odds of impaired SQOL (OR:1.61, 95% CI:0.09–1.08, P-value:0.023) (Table 6).

Table 6 Results of logistic regression associated with sexual quality of life
Full size table

Discussion

More than one-third of men with GWs had impaired overall sexual function in this study, and ED was the most common disorder. The prevalence of ED in this group was considerably higher than the pooled prevalence estimation in the general population from a meta-analysis of 11 studies (56.1%, 95% confidence interval [CI]: 40–72%) [19]. In addition, the prevalence of mild to moderate ED in the present study was higher than that of Asian men: 5 to 31.6% vs. 54.3% [20]. Prevalence of sexual dysfunction increases in certain conditions such as chronic diseases. Evaluation of ED using IIEF in some chronic diseases of Iranian men such as congestive heart failures, hemodialysis, diabetes mellitus type II showed that the prevalence of this disorder was about 80%, which was close to that found in men with GWs [19]. Therefore, it seems that GWs should be considered a condition that can negatively impact male sexual function, especially erectile function. The presence of ED in men with GWs is consistent with the study of Kucukunal et al. In this study, sexual dysfunction was also more common in men with GWs compared to the control group, and these men experienced more abnormalities in sex drive, arousal, penile erection, ability to reach orgasm and satisfaction from orgasm [11].

Regarding the study of the sexual function of these men, the El-Hamd study aimed to assess premature ejaculation (PE) frequency and intravaginal ejaculatory latency time. The results showed that 66.7% of men with GWs had PE. However, the rate of anxiety and PE in patients with GWs and PE disorder was higher and significantly higher than men who had GWs but did not have PE disorder compared to the control group (P = 0.001) [21].

The presence of sexual disorders, especially ED, in men with other STIs such as human immunodeficiency virus (HIV) and Herpes simplex virus (HSV) has also been reported, like HPV [8, 10]. In these diseases, in addition to atherosclerotic changes and problems with the organic vascular component sexual function that occurs in some diseases such as HSV, seems to cause psychological distress and emotional concerns about the possibility of partner involvement and the appearance of skin lesions, which can lead to the high attention to sexual performance during intercourse and lead to ED [8, 10].

Several studies have reported an association between age and ED. But most of these studies have focused on older men or men whose average age was over 40 years [22,23,24,25]. The absence of such an association in our study appears to be due to the low average age (approximately 30 years) of men with GWs in this study.

Published studies have reported different findings of the quality of life of people with GWs. To date, no study has focused specifically on the SQOL of people with GWs. Some of these studies suggest mild or no impairment of quality of life in men [26, 27], and some reported that the quality of life in people (men and women) is significantly lower [12, 28]. However, studies have shown that the effects of psychosocial GWs on the health-related quality of life of women are more significant than men [12, 29]. More than half of the men had a good SQOL in the present study, and about one-third had a moderate SQOL.

In the present study, sexual dysfunction had a noticeable impact on the SQOL and ED was associated with increase in odds of impaired SQOL. The study conducted by Owiredu et al. on men and women with physical disabilities showed that sexual dysfunction was higher in this group than healthy individuals, and this dysfunction significantly affected their SQOL [30]. This effect was also confirmed in men with GWs and without physical disability in the present study. A review article showed that men with ED have a poor quality of life and even more economic burden than men without ED [31]. The findings confirmed with Van Vo et al. study that one-third of the married men with ED reported having low quality of life [32]. Although, the result focused on general quality of life of men with ED, some studies revealed that ED adversely affects the relationship with a partner and decreased sexual satisfaction in their female partners [33,34,35]. It seems that ED, in addition to negatively impact on female partners’ sexual life, can also impose a substantial SQOL burden in men. The issue is consistent with the results of the current study.

Some potential limitations should be discussed. Nearly all men in this study were heterosexual. Therefore the results are not generalized in men with GWs with different sexual orientations. This study did not consider the severity of GWs, men’s stress and anxiety level, and sexual partner status in terms of suffering from GWs. Future studies should consider these variables, which may affect sexual function and SQOL.

Conclusions

The results showed that more than one-third of men with GWs had impaired overall sexual function, and most had ED. More than half of the men had a good SQOL, about a third had a moderate SQOL, and the level of sexual dysfunction clearly impacted the SQOL. ED was associated with impaired SQOL.These results could have an important application in a comprehensive and tailored view of the needs of men with GWs. Healthcare providers should pay more attention to the sexual function, and SQOL in men with GWs, as these can affect the sexual health of men and their sexual partners.

Availability of data and materials

The datasets used are available from the corresponding author upon reasonable request.

Abbreviations

ED:

Erectile dysfunction

GWs:

Genital warts

HIV:

Human immunodeficiency virus

HPV:

Human papillomavirus

HSV:

Herpes simplex virus

IIEF:

International Index of Erectile Function

PE:

Premature ejaculation

SD:

Sexual dysfunction

SQOL:

Sexual quality of life

SQOL-M:

Sexual Quality of Life-Men

STIs:

Sexually transmitted infections

References

  1. Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2019;68:698–702.

    Article  Google Scholar 

  2. World Health Organization (WHO). Sexually transmitted infections: Evidence brief. 2019. Document No.: WHO/RHR/19.22. https://apps.who.int/iris/handle/10665/329888. Accessed 15 Aug 2021.

  3. Gargano JW, Unger ER, Liu G, Steinau M, Meites E, Dunne E, et al. Prevalence of genital human papillomavirus in males, United States, 2013–2014. J Infect Dis. 2017;215:1070–79.

    Article  Google Scholar 

  4. Daugherty M, Byler T. Genital wart and human papillomavirus prevalence in men in the United States from penile swabs: results from national health and nutrition examination surveys. Sex Transm Dis. 2018;45:412–16.

    Article  Google Scholar 

  5. Hoy T, Singhal PK, Willey VJ, Insinga RP. Assessing incidence and economic burden of genital warts with data from a US commercially insured population. Curr Med Res Opin. 2009;25:2343–51.

    Article  Google Scholar 

  6. Qi SZ, Wang SM, Shi JF, Wang QQ, Chen XS, Sun LJ, et al. Human papillomavirus-related psychosocial impact of patients with genital warts in China: a hospital-based cross-sectional study. BMC Public Health. 2014;14:739.

    Article  Google Scholar 

  7. Lee TS, Kothari-Talwar S, Singhal PK, Yee K, Kulkarni A, Lara N, et al. Cross-sectional study estimating the psychosocial impact of genital warts and other anogenital diseases in South Korea. BMJ Open. 2019;9:e025035.

    Article  Google Scholar 

  8. De Vincentis S, Tartaro G, Rochira V, Santi D. HIV and sexual dysfunction in men. J Clin Med. 2021;10:1088.

    Article  Google Scholar 

  9. Brookings C, Goldmeier D, Sadeghi-Nejad H. Sexually transmitted infections and sexual function in relation to male fertility. Korean J Urol. 2013;54:149–56.

    Article  Google Scholar 

  10. Huang CC, Chan WL, Chen YC, Chen TJ, Chung CM, Huang PH, et al. Herpes simplex virus infection and erectile dysfunction: a nationwide population-based study. Andrology. 2013;1:240–4.

    Article  Google Scholar 

  11. Kucukunal A, Altunay IK, Mercan S. Sexual dysfunction in men suffering from genital warts. J Sex Med. 2013;10:1585–91.

    Article  Google Scholar 

  12. Nahidi M, Nahidi Y, Saghebi A, Kardan G, Jarahi L, Aminzadeh B, et al. Evaluation of psychopathology and quality of life in patients with anogenital wart compared to control group. Iran J Med Sci. 2018;43:65–9.

    PubMed  PubMed Central  Google Scholar 

  13. Lee Mortensen G, Larsen HK. Quality of life of homosexual males with genital warts: a qualitative study. BMC Res Notes. 2010;3:280.

    Article  Google Scholar 

  14. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822–30.

    Article  CAS  Google Scholar 

  15. Pakpour AH, Zeidi IM, Yekaninejad MS, Burri A. Validation of a translated and culturally adapted Iranian version of the International Index of Erectile Function. J Sex Marital Ther. 2014;40:541–51.

    Article  Google Scholar 

  16. Gonzáles AI, Sties SW, Wittkopf PG, Mara LS, Ulbrich AZ, Cardoso FL, et al. Validation of the International Index of Erectile Function (IIFE) for use in Brazil. Arq Bras Cardiol. 2013;101:176–82.

    PubMed  PubMed Central  Google Scholar 

  17. Abraham L, Symonds T, Morris MF. Psychometric validation of a sexual quality of life questionnaire for use in men with premature ejaculation or erectile dysfunction. J Sex Med. 2008;5:595–601.

    Article  Google Scholar 

  18. Maasoumi R, Mokarami H, Nazifi M, Stallones L, Taban A, Yazdani Aval M, et al. Psychometric Properties of the Persian translation of the sexual quality of life–male questionnaire. Am J Mens Health. 2017;11:564–72.

    Article  Google Scholar 

  19. Ramezani MA, Ahmadi K, Ghaemmaghami A, Marzabadi EA, Pardakhti F. Epidemiology of sexual dysfunction in Iran: a systematic review and meta-analysis. Int J Prev Med. 2015;6:43.

    Article  Google Scholar 

  20. Irfan M, Hussain NHN, Noor NM, Mohamed M, Sidi H, Ismail SB. Epidemiology of male sexual dysfunction in Asian and European regions: a systematic review. Am J Mens Health. 2020;14:1557988320937200.

    PubMed  PubMed Central  Google Scholar 

  21. Abu El-Hamd M. Premature ejaculation among patients with genital warts: a pilot study. Sex Relatsh Ther. 2020;35:424–32.

    Article  Google Scholar 

  22. Li C, Sun J, Zhao H, Dai T. Association between frailty and erectile dysfunction among Chinese elderly men. Biomed Res Int. 2020;2020:9247237.

    PubMed  PubMed Central  Google Scholar 

  23. Van Vo T, Hoang HD, Thanh Nguyen NP. Prevalence and associated factors of erectile dysfunction among married men in Vietnam. Front Public Health. 2017;5:94.

    Article  Google Scholar 

  24. Paulsen LH, Sørensen Bakke L, Jarbøl DE, Balasubramaniam K, Hansen DG. Associations between lifestyle, erectile dysfunction and healthcare seeking: a population-based study. Scand J Prim Health Care. 2020;38(2):176–83.

    Article  Google Scholar 

  25. Quilter M, Hodges L, von Hurst P, Borman B, Coad J. Male sexual function in New Zealand: a population-based cross-sectional survey of the prevalence of erectile dysfunction in men aged 40–70 years. J Sex Med. 2017;14:928–36.

    Article  Google Scholar 

  26. Camargo CC, D’Elia MPB, Miot HA. Quality of life in men diagnosed with anogenital warts. An Bras Dermatol. 2017;92:427–29.

    Article  Google Scholar 

  27. Kazeminejad A, Yazadani Charati J, Rahmatpour G, Masoudzadeh A, Bagheri S. Comparison of quality of life in anogenital warts with control. Tehran Univ Med J. 2019;76:692–98.

    Google Scholar 

  28. Domenech-Viñolas M, León-Maldonado L, Ramírez-Palacios P, Flores YN, Granados-García V, Brown B, et al. Incidence, psychosocial burden, and economic impact of genital warts in Mexico. Salud Publica Mex. 2018;60:624–32.

    Article  Google Scholar 

  29. Vriend HJ, Nieuwkerk PT, van der Sande MA. Impact of genital warts on emotional and sexual well-being differs by gender. Int J STD AIDS. 2014;25:949–55.

    Article  Google Scholar 

  30. Owiredu WK, Owusu AO, Amidu N, Quaye L, Gyasi-Sarpong CK, Dapare PP, et al. Sexual dysfunction and sexual quality of life among the physically challenged in the Kumasi metropolis, Ghana. Health Qual Life Outcomes. 2015;13:3.

    Article  Google Scholar 

  31. Elterman DS, Bhattacharyya SK, Mafilios M, Woodward E, Nitschelm K, Burnett AL. The quality of life and economic burden of erectile dysfunction. Res Rep Urol. 2021;13:79–86.

    PubMed  PubMed Central  Google Scholar 

  32. Van Vo T, Hoang HD, Thanh Nguyen NP. Prevalence and associated factors of erectile dysfunction among married men in Vietnam. Front Public Health. 2017;5:94.

    Article  Google Scholar 

  33. Zhang H, Fan S, Yip P. The association between female sexual dysfunction and the husband’s erectile dysfunction: evidence from married couples in Hong Kong. J Sex Marital Ther. 2016;42:214–22.

    Article  Google Scholar 

  34. Jiann BP, Su CC, Tsai JY. Is female sexual function related to the male partners’ erectile function? J Sex Med. 2013;10:420–29.

    Article  Google Scholar 

  35. Li H, Gao T, Wang R. The role of the sexual partner in managing erectile dysfunction. Nat Rev Urol. 2016;13:168–77.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This article is the result of the MSc thesis in midwifery by Ms. Marzieh Hosseini Nia (Project No: 1398-01-08-20025) funded by the Research Deputy of Shiraz University of Medical Sciences. Hereby, authors wish to express their gratitude to all the participating patients.

Funding

This study was funded by the Research Deputy of Shiraz University of Medical Sciences (Grant Number 20025).

Author information

Authors and Affiliations

  1. Student Research Committee, Department of Midwifery, School of Nursing and Midwifery, Shiraz University of Medical Sciences, Shiraz, Iran

    Marzieh Hosseini Nia

  2. Department of Midwifery, School of Nursing and Midwifery, Community Based Psychiatric Care Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

    Fatemeh Rahmanian & Roksana Janghorban

  3. Molecular Dermatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

    Mehdi Ghahartars

Authors
  1. Marzieh Hosseini Nia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fatemeh Rahmanian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mehdi Ghahartars
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Roksana Janghorban
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the study design. MH performed data collection. MH and RJ performed statistical analysis, interpretation of data and wrote all drafts of the manuscript. RJ, FR, and MG provided substantial feedback on the drafts of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Roksana Janghorban.

Ethics declarations

Ethics approval and consent to participate

The present study protocol was reviewed and approved by the National Committee of Ethics in Biomedical Research of Shiraz University of Medical Sciences, Iran (Ethical. No. IR.SUMS.REC.1398.743). Informed consent was submitted by all subjects when they were enrolled.

Consent for publication

Not applicable.

Competing interests

The authors declare that there are no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nia, M.H., Rahmanian, F., Ghahartars, M. et al. Sexual function and sexual quality of life in men with genital warts: a cross-sectional study. Reprod Health 19, 102 (2022). https://doi.org/10.1186/s12978-022-01403-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12978-022-01403-z

Keywords

Reproductive Health

ISSN: 1742-4755